Fig. 2From: A novel small molecule inhibitor of MDM2-p53 (APG-115) enhances radiosensitivity of gastric adenocarcinomaThe cell proliferation assay demonstrating the cell viability of the AGS (a) and MKN45 (b) cell lines, expressed as a percentage of control group by the CCK-8 assay. AGS (c) and MKN45 (d) cell lines were treated with APG-115 (0.02Â mol/L and 0.2Â mol/L) and/or radiation (4Gy) for 0 to 48Â h. Relative expression of MDM2, p21, PUMA and BAX mRNA compared with the control at 0Â h was determined by RT-qPCRBack to article page